Author Archives: Patricia Inacio PhD

Health Canada OKs Using Ferriprox for Iron Overload

Health Canada has expanded its approval of Chiesi Global Rare Diseases’ iron-binding oral treatment Ferriprox (deferiprone) to patients who have blood transfusion-induced iron overload due to sickle cell disease (SCD) or other anemias. The decision comes about five months after the U.S. Food and Drug Administration (FDA) approved…